论文信息 - Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC). - 字舞流文

Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC).

Jeffrey W. Clark | A. Drilon | M. Socinski | S. Ou | Gregory Riely | K. Wilner | P. Paik | D. Camidge | J. Weiss | Sherry Wang | M. Winter | Katherine Monti